MEDVi vs Mochi Health vs Yucca Health (2026)
On tirzepatide, the order is Yucca Health↗ ($258) → Mochi Health↗ ($278) → MEDVi↗ ($399) — gaps of $20 and then $121 a month, a $1,692 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
The three records, one screen
Yucca Health: the record, condensed
On tirzepatide, the number that matters at Yucca Health is $258 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.
There is no membership line. $258 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.
To place the number: #2 of 17 verified programs, with the floor $43/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $191 a month. A year at this figure: $3,096 monthly-billed.
On semaglutide, the number that matters at Yucca Health is $146 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at Yucca Health is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.
The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.
Context for that figure: it ranks #2 of 20 in the verified semaglutide index — $13/month above the floor (Oak Longevity, $133) — and sits $203 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $1,752.
Operationally at Yucca Health: shipping included; commitment 6-month term; cancellation 6-month term applies; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Yucca Health page · visit Yucca Health ↗
Mochi Health: the record, condensed
Start with the load-bearing figure: $278 a month, all-in, is what Mochi Health charges for tirzepatide at the 10 mg basis. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.
The all-in figure already contains a compulsory $79 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $199 would be exactly that kind of mirage.
Context for that figure: it ranks #4 of 17 in the verified tirzepatide index — $63/month above the floor (NexLife, $215) — and sits $171 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $3,336.
Mochi Health’s semaglutide program bills $178 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at Mochi Health is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.
Inside that $178 sits a mandatory $79-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $99, and it is not a price anyone can actually pay, because the membership cannot be declined.
To place the number: #8 of 20 verified programs, with the floor $45/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $171 a month. A year at this figure: $2,136 monthly-billed.
Operationally at Mochi Health: shipping included; commitment membership recurs monthly; cancellation cancel membership any time; recurs until cancelled; pharmacy named (company-owned compounding facility); states: most states; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Mochi Health page · visit Mochi Health ↗
MEDVi: the record, condensed
On tirzepatide, the number that matters at MEDVi is $399 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.
Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $399 is the whole subscription, which makes MEDVi unusually easy to compare and unusually easy to leave.
Context for that figure: it ranks #14 of 17 in the verified tirzepatide index — $184/month above the floor (NexLife, $215) — and sits $50 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $4,788.
MEDVi’s semaglutide program bills $299 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at MEDVi is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.
The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.
To place the number: #18 of 20 verified programs, with the floor $166/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $50 a month. A year at this figure: $3,588 monthly-billed.
Operationally at MEDVi: shipping included; commitment 12-month plan for the lowest rate; cancellation 12-month plan applies to lowest rate; pharmacy not publicly named — ask in writing before paying; states: priced differently in CA/NC on some plans; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the MEDVi page · visit MEDVi ↗
Prices, gaps, and what sits inside them
Yucca Health holds the low ground at $258 — dose-flat, so that figure is a ceiling with no membership attached. Mochi Health follows at $278 (+$20/mo, $240/yr), membership included. MEDVi tops the trio at $399 (+$141/mo over the leader, $1,692/yr) — note its record’s watch-out below.
The semaglutide picture reshuffles nothing: Yucca Health $146 → Mochi Health $178 → MEDVi $299 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.
Who wins what
Cheapest month-to-month: Yucca Health ($258); cheapest 12-month path: Yucca Health ($3,096); simplest billing (no membership): Yucca Health and MEDVi; named-pharmacy transparency: Mochi Health; cheapest semaglutide of the three: Yucca Health ($146).
Every winner above is a computation, not a placement; the pairwise pages carry the full duels: Yucca Health vs Mochi Health · Yucca Health vs MEDVi · Mochi Health vs MEDVi.
Everything besides the three prices
Memberships: Yucca Health none; Mochi Health $79/mo (inside its figure); MEDVi none. Structures: Yucca Health dose-flat; Mochi Health dose-flat; MEDVi dose-flat. Pharmacies: Yucca Health not named; Mochi Health named (company-owned compounding facility); MEDVi not named. States: Yucca Health — not published; Mochi Health — most states; MEDVi — priced differently in CA/NC on some plans. Exit terms: Yucca Health — 6-month term applies; Mochi Health — cancel membership any time; recurs until cancelled; MEDVi — 12-month plan applies to lowest rate.
The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: Yucca Health source-verified (2026-08-05); Mochi Health source-verified (2026-08-05); MEDVi source-verified (2026-08-05).
The trio on semaglutide, across time
3 mo: Yucca Health $438 vs Mochi Health $534 vs MEDVi $897 6 mo: Yucca Health $876 vs Mochi Health $1,068 vs MEDVi $1,794 12 mo: Yucca Health $1,752 vs Mochi Health $2,136 vs MEDVi $3,588 — monthly-billed totals; prepaid paths where published appear on each provider page.
The trio, annualized
Yucca Health: $3,096/yr monthly-billed; Mochi Health: $3,336/yr monthly-billed; MEDVi: $4,788/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $3,384 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.
The elimination read
A three-way choice is really two eliminations, so run them in order. Eliminate MEDVi first unless it names its edge: at $399 it carries a $141/month premium over the floor of this trio — $1,692 a year, about 6.6 extra months of therapy at Yucca Health’s rate — and a premium that size must point at a specific line in its record (its particular program design) or it is decoration. Then interrogate Mochi Health’s middle ground: its $79/mo membership bundles services the floor does not; if that specific thing is on your personal ledger, the $20/month over the floor can be rational — if not, the middle is where budgets go to leak. What survives is Yucca Health at $258, which wins by default rather than by argument — exactly how a price index should crown things — subject to the two checks no ranking can run for you: your state at intake, and your prescriber on the medication itself.
The same trio on best published rate: Yucca Health $258 → Mochi Health $278 → MEDVi $399 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — Yucca Health $774, Mochi Health $834, MEDVi $1,197; 6 months — Yucca Health $1,548, Mochi Health $1,668, MEDVi $2,394. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.
The record-quality read, scored on the five checkable disclosures this index tracks (maintenance price, named pharmacy, published states, published cancellation terms, source-verified capture): Yucca Health 4/5, Mochi Health 5/5, MEDVi 4/5. Mochi Health discloses the most and Yucca Health the least, and in this market disclosure predicts disclosure — the axis where a program goes quiet is reliably where its checkout surprises live. Where the trio actually splits: pharmacy named: Mochi Health yes, Yucca Health and MEDVi no — each split is a written intake question before any card number. Scores recompute from the public records like everything else here.
Read as a decision: start from Yucca Health and make the other two argue upward. Mochi Health’s case is its structure; MEDVi’s case must be worth $1,692 a year in named features — the honest unit being months of medication (6.6 of them at the floor rate). The pairwise pages above hold each argument in full, and the calculator holds your version of it.
Frequently asked
Which is cheapest: MEDVi, Mochi Health, or Yucca Health?
Yucca Health, at $258/month all-in tirzepatide — $20 under Mochi Health and $141 under MEDVi; on semaglutide the cheapest of the three is Yucca Health at $146. Captured 2026-08-09.
Which of the three is best over a full year?
Yucca Health’s best path prices twelve months at $3,096; monthly-billed years run Yucca Health $3,096, Mochi Health $3,336, MEDVi $4,788.
Are these rankings paid or editorial?
Neither — they are sorts of the public dataset on the all-in maintenance basis, regenerated on every data change; the methodology page defines the basis and the JSON lets you recompute every figure here.